How Viruses Hijack Cells to Replicate: A Step-by-Step Biology Explained

Not Quite Alive, Not Quite Dead

A virus outside a cell is inert. No metabolism. No movement. No replication. It's essentially a package of genetic information — DNA or RNA — wrapped in protein. Yet place that particle near the right cell, and within hours it can produce tens of thousands of copies of itself, often destroying the cell in the process. The SARS-CoV-2 coronavirus, for instance, needs only 10 hours from initial infection to produce its first new viral particles — all using machinery entirely stolen from the host cell.

Viruses are not classified as living organisms precisely because they lack any independent metabolic activity. They carry no ribosomes, no ATP-producing systems, no repair mechanisms. Everything they need for reproduction, they borrow. This fundamental dependency is both a biological weakness and, from the perspective of antivirals, a potential target for treatment.

Viral Structure: The Delivery Mechanism

Every virus, however diverse, consists of the same basic architecture. A genome — either single- or double-stranded DNA or RNA, ranging from 3 to 2,000 genes — is enclosed in a protein shell called the capsid. Many viruses are additionally wrapped in a lipid envelope derived from the host cell's membrane during a previous infection cycle.

The capsid isn't passive packaging. Its surface proteins determine which host cells the virus can infect — a property called tropism. HIV's gp120 protein specifically binds CD4 receptors on T cells. SARS-CoV-2's spike protein binds ACE2 receptors concentrated in lung, gut, and vascular tissue. The influenza hemagglutinin (HA) protein binds sialic acid residues on respiratory cells. Cell tropism explains why HIV infects immune cells, why rabies virus targets neurons, and why the hepatitis B virus attacks hepatocytes.

The Six Stages of Viral Replication

Stage 1: Attachment

Viral surface proteins bind to specific receptor molecules on the host cell surface. This interaction is chemically specific — like a lock and key. The binding is driven by molecular complementarity: the viral protein's shape and charge pattern matches the receptor's precisely. This specificity determines host range; a virus cannot infect a cell that lacks its receptor.

Stage 2: Entry

After attachment, the virus must get its genetic material inside the cell. Enveloped viruses (HIV, influenza, SARS-CoV-2) typically fuse their lipid envelope with the host cell membrane — either at the surface or after endocytosis — releasing the viral contents into the cytoplasm. Non-enveloped viruses (poliovirus, adenovirus) use receptor-mediated endocytosis; they enter the cell in an endosome and escape by disrupting the endosomal membrane at low pH.

Stage 3: Uncoating

Inside the cell, the viral capsid disassembles, releasing the genome. For RNA viruses that replicate in the cytoplasm, this happens quickly. For DNA viruses that replicate in the nucleus (herpesviruses, adenoviruses), the capsid travels along microtubules to nuclear pores and injects its genome through.

Stage 4: Replication and Transcription

This is the hijacking step. The virus uses host ribosomes to translate its genetic instructions into viral proteins. But different genome types require different strategies:

RNA viruses carry their own RNA-dependent RNA polymerase (RdRp) because cells don't normally copy RNA from RNA templates. This enzyme is why many antiviral drugs target RdRp — remdesivir, which was used against SARS-CoV-2 and Ebola, works by inserting a false nucleotide into the growing RNA chain, terminating replication.

Stage 5: Assembly

New viral proteins and replicated genome copies must find each other and self-assemble into new virions. This process is driven by molecular recognition — capsid proteins spontaneously fold into the correct geometry and enclose the genome. For complex viruses like herpesviruses, capsid assembly begins in the nucleus before migration to the cytoplasm. For retroviruses like HIV, assembly occurs at the plasma membrane, where Gag proteins polymerize and bud outward.

Stage 6: Release

Newly assembled virions exit the cell by one of two main routes. Lytic release: the cell bursts (lyses), releasing hundreds to thousands of new virions at once and killing the cell. This is typical of bacteriophages and many animal viruses including poliovirus. Budding: enveloped viruses like HIV and influenza pinch off through the plasma membrane, acquiring their lipid envelope in the process and allowing the cell to survive — at least temporarily — while shedding virions continuously.

Latency: When Viruses Wait

Some viruses establish latent infections — they integrate into the host genome or maintain their DNA in the nucleus without actively replicating. This is the lysogenic cycle, in contrast to the lytic replication described above. Herpesviruses are the classic example. After an initial infection, varicella-zoster virus (chickenpox) retreats to sensory ganglia and lies dormant for decades, suppressed by the immune system. When immunity wanes — due to stress, aging, or immunosuppression — the virus reactivates as shingles (herpes zoster).

• HIV can also establish latent reservoirs in long-lived T memory cells, where it integrates into the host genome and remains invisible to both the immune system and antiretroviral drugs. This latent reservoir is the main barrier to curing HIV.
• Epstein-Barr virus (EBV) infects nearly 95% of adults worldwide, remains latent in B cells for life, and is associated with several cancers including Burkitt's lymphoma and nasopharyngeal carcinoma when reactivated under certain conditions.

Mutation Rates and Viral Evolution

RNA viruses mutate far faster than DNA viruses because RNA polymerases lack proofreading activity, introducing roughly one error per 10,000 nucleotides copied — compared to DNA polymerase error rates of one per 10 billion. An RNA virus population is not a single genetic sequence but a swarm of slightly different variants called a quasispecies.

This rapid mutation rate is why influenza vaccines must be reformulated annually, why HIV develops drug resistance quickly, and why SARS-CoV-2 produced variants like Delta and Omicron that substantially changed the pandemic's course. The Omicron variant, first detected in November 2021, carried over 50 mutations relative to the original Wuhan strain — an unusually large divergence that researchers believe accumulated during prolonged replication in a severely immunocompromised individual.

Understanding viral replication at each stage has yielded the modern antiviral pharmacopeia. Oseltamivir (Tamiflu) blocks neuraminidase, preventing influenza release from cells. Nucleoside analogues like acyclovir terminate herpesvirus DNA synthesis. HIV treatment uses combination therapy targeting reverse transcriptase, protease, and integrase — three different enzymes in the viral replication cycle — making simultaneous resistance to all three vanishingly unlikely. Every antiviral drug, past or future, is ultimately an interference with one step of the cycle described here.